11β-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets

Diabetologia

Volumn 51, Issue 11, 2008, Pages 2003-2011

  Swali, A ^a   Walker, E A ^a   Lavery, G G ^a   Tomlinson, J W ^a   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

11 HSD1; Cortisol; Glucagon; Glucocorticoids; Insulin; Pancreatic islet

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; DEXAMETHASONE; GLUCAGON; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INSULIN; SOMATOSTATIN; ENZYME INHIBITOR; GALACTOSE 6 PHOSPHATE DEHYDROGENASE; GALACTOSE-6-PHOSPHATE DEHYDROGENASE; GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA; OXIDOREDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEMALE; GLUCAGON RELEASE; HORMONE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HOMEOSTASIS; METABOLISM; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CARBOHYDRATE DEHYDROGENASES; DEXAMETHASONE; ENZYME INHIBITORS; FEMALE; GLUCAGON; HOMEOSTASIS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 53549105499     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1137-2     Document Type: Article

References (43)

1. RW Hanson AJ Garber 1972 Phosphoenolpyruvate carboxykinase. 1. Its role in gluconeogenesis Am J Clin Nutr 25 1010 1021
2. MW Voice AP Webster A Burchell 1997 The in vivo regulation of liver and kidney glucose-6-phosphatase by dexamethasone Horm Metab Res 29 97 100
3. H Larsson B Ahren 1996 Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women J Clin Endocrinol Metab 81 4428 4432
4. B Davani A Khan M Hult 2000 Type 1 11 beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets J Biol Chem 275 34841 34844
5. C Lambillotte P Gilon JC Henquin 1997 Direct glucocorticoid inhibition of insulin secretion - An in vitro study of dexamethasone effects in mouse islets J Clin Invest 99 414 423
6. H Ortsater P Alberts U Warpman LOM Engblom L Abrahmsen P Bergsten 2005 Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans Diabetes Metab Res Rev 21 359 366
7. B Fischer U Rausch P Wollny H Westphal J Seitz G Aumuller 1990 Immunohistochemical localization of the glucocorticoid receptor in pancreatic beta-cells of the rat Endocrinology 126 2635 2641
8. IK Jeong SH Oh BJ Kim 2001 The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment Diabetes Res Clin Pract 51 163 171
9. B Billaudel BCJ Sutter 1979 Direct effect of corticosterone upon insulin-secretion studied by 3 different techniques Horm Metab Res 11 555 560
10. G Barseghian R Levine 1980 Effect of corticosterone on insulin and glucagon-secretion by the isolated perfused rat pancreas Endocrinology 106 547 552
11. J Pierluissi FO Navas SJH Ashcroft 1986 Effect of adrenal-steroids on insulin release from cultured rat islets of Langerhans Diabetologia 29 119 121
12. J Brunstedt JH Nielsen 1981 Direct long-term effect of hydrocortisone on insulin and glucagon-release from mouse pancreatic-islets in tissue-culture Acta Endocrinol (Copenh) 96 498 504
13. A Kawai N Kuzuya 1977 Role of glucocorticoid in glucose-induced insulin-secretion Horm Metab Res 9 361 365
14. F Delaunay A Khan A Cintra 1997 Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids J Clin Invest 100 2094 2098
15. IJ Bujalska S Kumar PM Stewart 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349 1210 1213
16. PM Stewart 1996 11 beta-hydroxysteroid dehydrogenase: implications for clinical medicine Clin Endocrinol 44 493 499
17. IJ Bujalska N Draper Z Michailidou 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1 J Mol Endocrinol 34 675 684
18. JM Paterson NM Morton C Fievet 2004 Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc Natl Acad Sci USA 101 7088 7093
19. H Masuzaki J Paterson H Shinyama 2001 A transgenic model of visceral obesity and the metabolic syndrome Science 294 2166 2170
20. H Masuzaki H Yamamoto CJ Kenyon 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice J Clin Invest 112 83 90
21. Y Kotelevtsev MC Holmes A Burchell 1997 11 beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress Proc Natl Acad Sci USA 94 14924 14929
22. GG Lavery EA Walker N Draper 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation J Biol Chem 281 6546 6551
23. ML Ricketts JM Verhaeg I Bujalska AJ Howie WE Rainey PM Stewart 1998 Immunohistochemical localization of type 1 11 beta-hydroxysteroid dehydrogenase in human tissues J Clin Endocrinol Metab 83 1325 1335
24. IJ Bujalska LL Gathercole JW Tomlinson 2008 A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis J Endocrinol 197 297 307
25. PS Brereton RR van Driel F Suhaimi K Koyama R Dilley Z Krozowski 2001 Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat Endocrinology 142 1644 1651
26. S Gremlich R Roduit B Thorens 1997 Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic beta cells - Comparison with the effects of fatty acids J Biol Chem 272 3216 3222
27. A Khan HL Cao BR Landau 1995 Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone Endocrinology 136 1934 1938
28. A Khan CG Ostenson PO Berggren S Efendic 1992 Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic-islets of ob/ob mice Am J Physiol 263 E663 E666
29. H Jamal PM Jones J Byrne 1991 Peptide contents of neuropeptide-Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic-acids after dexamethasone treatment in the isolated rat islets of Langerhans Endocrinology 129 3372 3380
30. D Hamamdzic E Duzic JD Sherlock SM Lanier 1995 Regulation of alpha(2)-adrenergic receptor expression and signaling in pancreatic beta-cells Am J Physiol 32 E162 E171
31. C Fernandez-Mejia O Medina-Martinez L Martinez-Perez PA Goodman 1999 The human insulin gene contains multiple transcriptional elements that respond to glucocorticoids Pancreas 18 336 341
32. JK Wise R Hendler P Felig 1973 Influence of glucocorticoids on glucagon secretion and plasma amino-acid concentrations in Man J Clin Invest 52 2774 2782
33. J Marco C Calle JA Hedo ML Villanueva 1976 Enhanced glucagon-secretion by pancreatic-islets from prednisolone-treated mice Diabetologia 12 307 311
34. N Abrahamsen E Nishimura 1995 Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3′,5′-monophosphate, and glucocorticoids Endocrinology 136 1572 1578
35. IH Song F Buttgereit 2006 Non-genomic glucocorticoid effects to provide the basis for new drug developments Mol Cell Endocrinol 246 142 146
36. J Gromada WG Ding S Barg E Renstrom P Rorsman 1997 Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors Pflugers Arch 434 515 524
37. H Sorensen MS Winzell CL Brand 2006 Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function Diabetes 55 3463 3469
38. P Huypens Z Ling D Pipeleers F Schuit 2000 Glucagon receptors on human islet cells contribute to glucose competence of insulin release Diabetologia 43 1012 1019
39. P Alberts L Engblom N Edling 2002 Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Diabetologia 45 1528 1532
40. EE Kershaw NM Morton H Dhillon L Ramage JR Seck JS Flier 2005 Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity Diabetes 54 1023 1031
41. BG Bhat N Hosea A Fanjul 2008 Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4′-cyano-biphenyl- 4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11 -hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys J Pharmacol Exp Ther 324 299 305
42. P Alberts C Nilsson G Selen 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains Endocrinology 144 4755 4762
43. A Hermanowski-Vosatka JM Balkovec K Cheng 2005 11 beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice J Exp Med 202 517 527